Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on July 10, 2008

Stroke. 2008
Published online before print July 10, 2008, doi: 10.1161/STROKEAHA.107.507020
A more recent version of this article appeared on September 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/9/2467    most recent
STROKEAHA.107.507020v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muñoz Maniega, S.
Right arrow Articles by Wardlaw, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muñoz Maniega, S.
Right arrow Articles by Wardlaw, J. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLINE BITARTRATE
*CHOLINE CHLORIDE
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging

Submitted on October 12, 2007
Revised on January 4, 2008
Accepted on January 30, 2008

Choline and Creatine Are Not Reliable Denominators for Calculating Metabolite Ratios in Acute Ischemic Stroke

Susana Muñoz Maniega PhD*; Vera Cvoro MD; Paul A. Armitage PhD; Ian Marshall PhD; Mark E. Bastin DPhil; and Joanna M. Wardlaw MD

From Clinical Neurosciences (S.M.M., V.C., P.A.A., J.M.W.), and Medical Physics (I.M., M.E.B.), University of Edinburgh, Western General Hospital, Edinburgh, UK.

* To whom correspondence should be addressed. E-mail: s.m.maniega{at}ed.ac.uk.

Background and Purpose—Choline and creatine are commonly used as denominators for other metabolites in ischemic stroke spectroscopy, assuming that they do not change. We investigated their concentration variation over time after stroke.

Methods—Choline and creatine concentrations were measured by proton MR spectroscopic imaging in 51 patients at 5 times up to 3 months after stroke.

Results—Choline and creatine levels changed significantly in the ischemic region. Choline was significantly reduced during the first 2 weeks after stroke onset (P=0.034). Creatine was significantly reduced during the whole period of the study (P=0.011).

Conclusion—Choline and creatine concentrations are not reliable denominators for metabolite ratios in acute stroke because their levels vary significantly in ischemic brain regions.


Key words: acute ischemic stroke • MR spectroscopy • metabolic ratios




This article has been cited by other articles:


Home page
BrainHome page
B. Karaszewski, J. M. Wardlaw, I. Marshall, V. Cvoro, K. Wartolowska, K. Haga, P. A. Armitage, M. E. Bastin, and M. S. Dennis
Early brain temperature elevation and anaerobic metabolism in human acute ischaemic stroke
Brain, April 3, 2009; (2009) awp010v1.
[Abstract] [Full Text] [PDF]